# Low starting-dosage of nintedanib for the reduction of early termination

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/low-starting-dosage-of-nintedanib-for-the-reduction-of-early-termination/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Satoshi Ikeda,Akimasa Sekine,Tomohisa Baba,Takuma Katano,Erina Tabata,Ryota Shintani,Hideaki Yamakawa,Takashi Niwa,T. Oda,Ryo Okuda,Hideya Kitamura,Takashi Ogura |
| Citations | 18 |
| DOI | 10.1016/j.resinv.2018.12.010 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2913878462 |
| PMID | 30772264 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Ryota Shintani](https://scholariq.org/researchers/ryota-shintani/)

## Paper primary topic

- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)

## Paper topics

- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Medical Imaging and Pathology Studies](https://scholariq.org/topics/medical-imaging-and-pathology-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.